|
⚲
|
| Keyboard |
| Link David Charles
✚
|
|
|---|---|
| CIK # | 0001889464 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001889464] | |
| 4 | [0001889464] | |
| 5 | [0001889464] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| SAB Biotherapeutics Inc | |
| Link David Charles | |
| Telix QSAM Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
SAB Biotherapeutics Inc SABS
Stock Option (right to buy) · derivative
|
2024-07-15 | Grant | 9,305 | $0.00 | |
|
SAB Biotherapeutics Inc SABS
Stock Option (right to buy) · derivative
|
2024-07-15 | Grant | 20,000 | $0.00 | |
|
SAB Biotherapeutics Inc SABS
Common Stock
|
2022-12-07 | Grant | 41,493 | $1.21 | 50,207 |
|
SAB Biotherapeutics Inc SABS
Warrant (Common Stock) · derivative
|
2022-12-07 | Grant | 41,493 | ||
|
Telix QSAM Inc QSAM
Series E-1 Preferred Stock
|
2021-12-06 | Other | 850 | ||
|
Telix QSAM Inc QSAM
Common Stock
|
2021-12-06 | Other | 2,883,943 | ||
|
SAB Biotherapeutics Inc SABS
Employee Stock Option (right to buy) · derivative
|
2021-10-22 | Grant | 69,793 | ||
|
SAB Biotherapeutics Inc SABS
Earnout Rights (Restricted Stock Units) · derivative
|
2021-10-22 | Grant | 17,231 | ||
|
SAB Biotherapeutics Inc SABS
Common Stock
|
2021-10-22 | Grant | 15,820 | ||
|
SAB Biotherapeutics Inc SABS
Common Stock
|
2021-10-22 | Grant | 12,097 | ||
|
SAB Biotherapeutics Inc SABS
Employee Stock Option (right to buy) · derivative
|
2021-10-22 | Grant | 23,264 | ||
|
SAB Biotherapeutics Inc SABS
Earnout Rights (Common Stock) · derivative
|
2021-10-22 | Grant | 4,887 | ||
|
SAB Biotherapeutics Inc SABS
Earnout Rights (Common Stock) · derivative
|
2021-10-22 | Grant | 6,391 | ||
|
Telix QSAM Inc QSAM
Options to buy common · derivative
|
2021-08-24 | Grant | 55,000 | $0.00 | |
|
Telix QSAM Inc QSAM
Series E-1 Preferred Shares · derivative
|
2021-02-15 | Grant | 850 | $0.00 |